Tissue thyroid hormone levels in critical illness

被引:99
作者
Peeters, RP
van der Geyten, S
Wouters, PJ
Darras, VM
van Toor, H
Kaptein, E
Visser, TJ
Van den Berghe, G [1 ]
机构
[1] Katholieke Univ Leuven, Dept Intens Care Med, B-3000 Louvain, Belgium
[2] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands
[3] Katholieke Univ Leuven, Lab Comparat Endocrinol, Zool Inst, B-3000 Louvain, Belgium
关键词
D O I
10.1210/jc.2005-1013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Pronounced alterations in serum thyroid hormone levels occur during critical illness. T(3) decreases and rT(3) increases, the magnitudes of which are related to the severity of disease. It is unclear whether these changes are associated with decreased tissue T(3) concentrations and, thus, reduced thyroid hormone bioactivity. Patients and Study Questions: We therefore investigated, in 79 patients who died after intensive care and who did or did not receive thyroid hormone treatment, whether total serum thyroid hormone levels correspond to tissue levels in liver and muscle. Furthermore, we investigated the relationship between tissue thyroid hormone levels, deiodinase activities, and monocarboxylate transporter 8 expression. Results: Tissue iodothyronine levels were positively correlated with serum levels, indicating that the decrease in serum T(3) during illness is associated with decreased levels of tissue T(3). Higher serum T(3) levels in patients who received thyroid hormone treatment were accompanied by higher levels of liver and muscle T(3), with evidence for tissuespecific regulation. Tissue rT(3) and the T(3)/rT(3) ratio were correlated with tissue deiodinase activities. Monocarboxylate transporter 8 expression was not related to the ratio of the serum over tissue concentration of the different iodothyronines. Conclusion: Our results suggest that, in addition to changes in the hypothalamus-pituitary-thyroid axis, tissue-specific mechanisms are involved in the reduced supply of bioactive thyroid hormone in critical illness.
引用
收藏
页码:6498 / 6507
页数:10
相关论文
共 40 条
[1]   REDUCED TISSUE THYROID-HORMONE LEVELS IN FATAL ILLNESS [J].
AREM, R ;
WIENER, GJ ;
KAPLAN, SG ;
KIM, HS ;
REICHLIN, S ;
KAPLAN, MM .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (09) :1102-1108
[2]   THE RELATIONSHIP BETWEEN SERUM TRIIODOTHYRONINE AND THYROTROPIN DURING SYSTEMIC ILLNESS [J].
BACCI, V ;
SCHUSSLER, GC ;
KAPLAN, TB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 54 (06) :1229-1235
[3]   HYPERMETABOLIC LOW TRIIODOTHYRONINE SYNDROME OF BURN INJURY [J].
BECKER, RA ;
VAUGHAN, GM ;
ZIEGLER, MG ;
SERAILE, LG ;
GOLDFARB, IW ;
MANSOUR, EH ;
MCMANUS, WF ;
PRUITT, BA ;
MASON, AD .
CRITICAL CARE MEDICINE, 1982, 10 (12) :870-875
[4]   Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study [J].
Bettendorf, M ;
Schmidt, KG ;
Grulich-Henn, J ;
Ulmer, HE ;
Heinrich, UE .
LANCET, 2000, 356 (9229) :529-534
[5]   Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases [J].
Bianco, AC ;
Salvatore, D ;
Gereben, B ;
Berry, MJ ;
Larsen, PR .
ENDOCRINE REVIEWS, 2002, 23 (01) :38-89
[6]  
BRENT GA, 1986, J CLIN ENDOCR METAB, V63, P1
[7]   The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus [J].
Canani, LH ;
Capp, C ;
Dora, JM ;
Meyer, ELS ;
Wagner, MS ;
Harney, JW ;
Larsen, PR ;
Gross, JL ;
Bianco, AC ;
Maia, AL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (06) :3472-3478
[8]   Dangerous dogmas in medicine: The nonthyroidal illness syndrome [J].
De Groot, LJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01) :151-164
[9]   EFFECTS OF MATERNAL HYPOTHYROIDISM ON THE WEIGHT AND THYROID-HORMONE CONTENT OF RAT EMBRYONIC-TISSUES, BEFORE AND AFTER ONSET OF FETAL THYROID-FUNCTION [J].
DEESCOBAR, GM ;
PASTOR, R ;
OBREGON, MJ ;
DELREY, FE .
ENDOCRINOLOGY, 1985, 117 (05) :1890-1900
[10]  
DEESCOBAR GM, 1994, ENDOCRINOLOGY, V134, P2410